Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date

Evaluating the Safety and Efficacy of Nivolumab in Patients with Advanced Hepatocellular Carcinoma: Evidence to Date

Sri Harsha Tella,1 Amit Mahipal,2 Anuhya Kommalapati,3 Zhaohui Jin2 1Department of Internal Medicine, University of South Carolina School of Medicine, Columbia, SC, USA; 2Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA; 3Department of Hematology and Medical Oncology, H. Lee Moffitt C...

Full description

Bibliographic Details
Main Authors: Tella SH, Mahipal A, Kommalapati A, Jin Z
Format: Article
Language:English
Published: Dove Medical Press 2019-11-01
Series:OncoTargets and Therapy
Subjects:
liver cancer
immunotherapy
nivolumab
lenvatinib
sorafenib
Online Access:https://www.dovepress.com/evaluating-the-safety-and-efficacy-of-nivolumab-in-patients-with-advan-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/evaluating-the-safety-and-efficacy-of-nivolumab-in-patients-with-advan-peer-reviewed-article-OTT

Similar Items